Rapid Disease Control in First-Line Therapy-Resistant Mucous Membrane Pemphigoid and Bullous Pemphigoid with Omalizumab as Add-On Therapy: A Case Series Of 13 Patients

The role of IgE autoantibodies has been demonstrated in the pathogenesis of bullous pemphigoid for many years. Recently, omalizumab (OMZ), a humanized monoclonal anti-IgE antibody that depletes total serum IgE, has been used off-label in a few case series of bullous pemphigoids demonstrating a rapid...

Descripción completa

Detalles Bibliográficos
Autores principales: Alexandre, Marina, Bohelay, Gérôme, Gille, Thomas, Le Roux-Villet, Christelle, Soued, Isaac, Morin, Florence, Caux, Frédéric, Grootenboer-Mignot, Sabine, Prost-Squarcioni, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065717/
https://www.ncbi.nlm.nih.gov/pubmed/35514989
http://dx.doi.org/10.3389/fimmu.2022.874108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065717/
https://www.ncbi.nlm.nih.gov/pubmed/35514989
http://dx.doi.org/10.3389/fimmu.2022.874108

Ejemplares similares